60
Биологическое лечение рака молочной железы Доктор Бэлла Нисенбаум 25 января 2010 года

Lecture in Russian on Breast Cancer - Dr. Nissenbaum

Embed Size (px)

DESCRIPTION

Biological Treatments for Breast Cancer

Citation preview

  • 1. 25 2010
  • 2. ?
    • , :
      • , , .
    • - (Targeted therapy)
      • , ,
  • 3.
  • 4.
    • -
  • 5.
    • ,
  • 6. (Targeted therapy)
    • ,
    • ( ), ,
  • 7. -
  • 8. , , Tykerb Trastuzumab ErbB3 ErbB2 ErbB1 ErbB2 Pertuzumab IGF-IR Pazopanib Bevacizumab Ertumaxomab Tanespimycin Alvespimycin Vorinostat Temsirolimus Everolimus Sunitinib HDAC=histone deacetylase VEGF PDGFR VEGFR Vascular endothelial cell membrane PI3K mTOR Akt HSP90 HDAC
  • 9.
      • Herceptin
      • ( Tykerb )
      • TDM1
      • PARP
  • 10.
  • 11. -
    • -: ,
    • -: , , -
    • HER-2 -, - ( Herceptin)
    • -: HER -2 , ,
  • 12. HER-2
    • ~ 20% HER-2
  • 13. HER
  • 14. HER-2 ,
  • 15. ?
  • 16. R-2 Herceptin HER-2 , ,
  • 17. Herceptin
  • 18. Herceptin H R-2
  • 19. HERCEPTIN
    • Herceptin , , ,
  • 20. HERCEPTIN
    • Herceptin ,
  • 21. HERCEPTIN , 52% 46% 40%
  • 22. Herceptin: 10- Weisgerber-Kriegl et al. ASCO 2008 abstract 6589
  • 23. HERCEPTIN HER-2
    • -
    • - , , ( beyond progression)
  • 24. HERCEPTIN HER-2
  • 25. R-2 ( Tykerb) HER -2 ,
  • 26. - , Ligands HER-2 Other ErbB PI3K/Akt pathway MAPK pathway (Ras/Raf/ MEK/ERK) PI3K/Akt pathway MAPK pathway (Ras/Raf/ MEK/ERK)
  • 27. , ( Tykerb)
    • HER-2 -
    • - , HER-2 , HER-2 , Herceptin
  • 28.
    • - :
  • 29.
  • 30.
    • Herceptin, ( )
  • 31.
    • + , 2007 ( FDA)
    • 2010
  • 32. ,
  • 33. - () ( VEGF) EGF IGF-1 PDGF IL-8 bFGF COX-2 NO VEGF H 2 O 2 P P P P IGF = insulin-like growth factor PDGF = platelet-derived growth factor
  • 34. VEGF -
      • VEGF ,
  • 35. ?
    • ( VEGF) -
  • 36. , ( VEGF)
    • -,
    VEGF
  • 37. ( VEGF) -
  • 38. 1 2 3 1 2 3 1 . Willett et, al. Nat Med 2004; 2 . Baluk, et al. Curr Opin Genet Dev 2005; 3 . Inai, et al. Am J Pathol 2004; 4 . Gerber, et al. Cancer Res 2005; 5 . Jain. Science 2005
  • 39.
    • , , ,
  • 40.
    • : , ,
    • (beyond progression)
    • ,
  • 41.
  • 42.
    • ,
    • , ,
  • 43.
  • 44. HER-2
    • - DM1 Herceptin
    • TDM1
  • 45. TDM1
    • HER-2
      • HER-2
  • 46. PARP
  • 47.
    • , - ( BRCA, PARP . )
    • ,
  • 48. PARP+ BRCA+
  • 49.
    • BRCA1-2
      • ( )
    • BRCA - , ( - triple negative)
  • 50. BRCA PARP (1) BRCA PARP++
  • 51. BRCA PARP (2) BRCA PARP++
  • 52. ?
  • 53. PARP
    • PARP BRCA ,
  • 54. PARP PARP- BRCA
  • 55. PARP
    • ( 2) PARP :
      • BRCA1-2
      • -
  • 56.
    • HER-2 .
    • Herceptin- HER-2
    • HER-2 ()
  • 57.
    • - -,
  • 58.
    • - ,
  • 59.
    • ...
  • 60.